Further studies are warranted to identify SNARE proteins that play similar protective roles in human podocytes, or mouse models, and to advance the design of SNARE-like (or SRA-like) peptides capable of binding the APOL1-RA proteins as therapeutics to prevent the progression of APOL1-associated CKD. This evidence concerns the gene APOL1 and chronic kidney disease.